March 31, 2021
by Barbara Dunford
Comments Off on Press Release March 31, 2020

Press Release March 31, 2020

CAPSTONE THERAPEUTICS ANNOUNCES OPERATING RESULTS FOR FISCAL 2020 – INCLUDING A CHANGE IN ITS DEFERRED TAX VALUATION ALLOWANCE

February 18, 2021
by Barbara Dunford
Comments Off on Press Release February 18, 2021

Press Release February 18, 2021

CAPSTONE THERAPEUTICS ANNOUNCES RESULTS OF SPECIAL SHAREHOLDER MEETING, AND A LICENSE TRANSFER/ROYALTY AGREEMENT AND EXIT FROM THE PHARMACEUTICAL DEVELOPMENT BUSINESS

December 28, 2020
by Barbara Dunford
Comments Off on Press Release December 28, 2020

Press Release December 28, 2020

Capstone Therapeutics Announces Exercise of Secured Debt and Interest Conversion Option by BP Peptides, LLC and Change in Control